Keystone Financial Group (Kentucky)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.8K | Hold |
14,000
| – | – | ﹤0.01% | 425 |
|
2025
Q1 | $16.2K | Hold |
14,000
| – | – | ﹤0.01% | 394 |
|
2024
Q4 | $17.8K | Hold |
14,000
| – | – | ﹤0.01% | 390 |
|
2024
Q3 | $47.7K | Buy |
+14,000
| New | +$47.7K | 0.01% | 369 |
|
2024
Q2 | – | Sell |
-14,000
| Closed | -$104K | – | 193 |
|
2024
Q1 | $104K | Hold |
14,000
| – | – | 0.02% | 342 |
|
2023
Q4 | $142K | Hold |
14,000
| – | – | 0.02% | 290 |
|
2023
Q3 | $109K | Hold |
14,000
| – | – | 0.02% | 295 |
|
2023
Q2 | $115K | Buy |
+14,000
| New | +$115K | 0.02% | 296 |
|
2022
Q4 | $124K | Hold |
14,000
| – | – | 0.02% | 275 |
|
2022
Q3 | $171K | Hold |
14,000
| – | – | 0.03% | 268 |
|
2022
Q2 | $166K | Buy |
+14,000
| New | +$166K | 0.03% | 278 |
|